NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 53 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8,123 | -75.4% | 25,126 | -2.1% | 0.00% | – |
Q4 2021 | $33,000 | -50.7% | 25,658 | -39.3% | 0.00% | – |
Q2 2021 | $67,000 | -36.8% | 42,251 | -1.9% | 0.00% | – |
Q3 2020 | $106,000 | -64.2% | 43,052 | -48.3% | 0.00% | – |
Q2 2020 | $296,000 | +557.8% | 83,321 | +337.1% | 0.00% | – |
Q1 2020 | $45,000 | +2.3% | 19,063 | +40.2% | 0.00% | – |
Q3 2016 | $44,000 | – | 13,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEDBUSH SECURITIES INC | 277,177 | $915,000 | 0.11% |
WEBSTER BANK, N. A. | 50,000 | $165,000 | 0.02% |
Brown Advisory Securities, LLC | 28,000 | $92,000 | 0.02% |
SIMPLEX TRADING, LLC | 50,804 | $167,000 | 0.01% |
GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $83,000 | 0.00% |
GROUP ONE TRADING, L.P. | 89,372 | $295,000 | 0.00% |
Squarepoint Ops LLC | 10,194 | $34,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,851 | $6,000 | 0.00% |
WOLVERINE TRADING, LLC | 58,500 | $193,000 | 0.00% |
WOLVERINE TRADING, LLC | 61,690 | $204,000 | 0.00% |